首页 正文

Borrowing from Historical Control Data in Cancer Drug Development: A Cautionary Tale and Practical Guidelines

{{output}}
Some clinical trialists, especially those working in rare or pediatric disease, have suggested borrowing information from similar but already-completed clinical trials. This paper begins with a case study in which relying solely on historical control informati... ...